Allgens Medical (China) Performance
| 688613 Stock | 17.15 0.16 0.94% |
On a scale of 0 to 100, Allgens Medical holds a performance score of 8. The firm shows a Beta (market volatility) of 0.6, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Allgens Medical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Allgens Medical is expected to be smaller as well. Please check Allgens Medical's coefficient of variation, jensen alpha, and the relationship between the downside deviation and standard deviation , to make a quick decision on whether Allgens Medical's price patterns will revert.
Risk-Adjusted Performance
8 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Allgens Medical Technology are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Allgens Medical sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Forward Dividend Yield 0.0035 | Payout Ratio 1.5003 | Forward Dividend Rate 0.06 | Ex Dividend Date 2024-07-09 |
1 | The surprising reason youre safer from allergic reactions in-flight than on the ground - New York Post | 10/15/2024 |
| Begin Period Cash Flow | 259.9 M |
Allgens |
Allgens Medical Relative Risk vs. Return Landscape
If you would invest 1,409 in Allgens Medical Technology on September 1, 2024 and sell it today you would earn a total of 306.00 from holding Allgens Medical Technology or generate 21.72% return on investment over 90 days. Allgens Medical Technology is generating 0.4023% of daily returns and assumes 3.6239% volatility on return distribution over the 90 days horizon. Simply put, 32% of stocks are less volatile than Allgens, and 92% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Allgens Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Allgens Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Allgens Medical Technology, and traders can use it to determine the average amount a Allgens Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.111
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | 688613 | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.62 actual daily | 32 68% of assets are more volatile |
Expected Return
| 0.4 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.11 actual daily | 8 92% of assets perform better |
Based on monthly moving average Allgens Medical is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Allgens Medical by adding it to a well-diversified portfolio.
Allgens Medical Fundamentals Growth
Allgens Stock prices reflect investors' perceptions of the future prospects and financial health of Allgens Medical, and Allgens Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Allgens Stock performance.
| Return On Equity | 3.0E-4 | ||||
| Return On Asset | -0.0136 | ||||
| Profit Margin | 0.03 % | ||||
| Operating Margin | (0.10) % | ||||
| Current Valuation | 1.29 B | ||||
| Shares Outstanding | 135.55 M | ||||
| Price To Book | 1.62 X | ||||
| Price To Sales | 12.16 X | ||||
| Revenue | 226.48 M | ||||
| Gross Profit | 204.53 M | ||||
| EBITDA | (12.88 M) | ||||
| Net Income | 54.23 M | ||||
| Total Debt | 5.07 M | ||||
| Book Value Per Share | 10.49 X | ||||
| Cash Flow From Operations | 51.68 M | ||||
| Earnings Per Share | 0.04 X | ||||
| Total Asset | 1.53 B | ||||
| Retained Earnings | 275.99 M | ||||
About Allgens Medical Performance
By analyzing Allgens Medical's fundamental ratios, stakeholders can gain valuable insights into Allgens Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Allgens Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Allgens Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Allgens Medical is entity of China. It is traded as Stock on SHG exchange.Things to note about Allgens Medical Tech performance evaluation
Checking the ongoing alerts about Allgens Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Allgens Medical Tech help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Allgens Medical Tech had very high historical volatility over the last 90 days | |
| Allgens Medical Tech has high likelihood to experience some financial distress in the next 2 years | |
| About 43.0% of the company shares are owned by insiders or employees |
- Analyzing Allgens Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Allgens Medical's stock is overvalued or undervalued compared to its peers.
- Examining Allgens Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Allgens Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Allgens Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Allgens Medical's stock. These opinions can provide insight into Allgens Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Allgens Stock analysis
When running Allgens Medical's price analysis, check to measure Allgens Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Allgens Medical is operating at the current time. Most of Allgens Medical's value examination focuses on studying past and present price action to predict the probability of Allgens Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Allgens Medical's price. Additionally, you may evaluate how the addition of Allgens Medical to your portfolios can decrease your overall portfolio volatility.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |